A5035089831- Blood Pressure and Hypertension Studies
- Hormonal Regulation and Hypertension
- Venous Thromboembolism Diagnosis and Management
- Muscle and Compartmental Disorders
- Diabetes Treatment and Management
- Medical Imaging and Pathology Studies
- Cardiovascular Health and Disease Prevention
- Omental and Epiploic Conditions
- Renal and Vascular Pathologies
- Heart Rate Variability and Autonomic Control
- Body Contouring and Surgery
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Vascular Procedures and Complications
- Ultrasound and Hyperthermia Applications
- Sodium Intake and Health
- Neonatal Respiratory Health Research
- Diabetes Management and Research
- SARS-CoV-2 and COVID-19 Research
- Renin-Angiotensin System Studies
- Cardiovascular Syncope and Autonomic Disorders
- Heart Failure Treatment and Management
- Medication Adherence and Compliance
- Cerebrovascular and Carotid Artery Diseases
- Data-Driven Disease Surveillance
- Pharmacology and Obesity Treatment
TriNetX (United States)
2018-2019
MSD (Germany)
1998-2002
University of Bonn
1989
The relative efficacy of antihypertensive treatment has been assessed primarily by randomized clinical trials (RCTs). increasing availability electronic medical records (EMR) allows results from RCT to be compared data actual practice. EMR TriNetX were used compare patients starting and adhering on diuretics, beta blockers, angiotensin II or ACE inhibitors, calcium channel blockers for at least 36 months. Cardiovascular (CV) events as defined ICD-10 codes evaluated an observation period...
To evaluate the effect on cardiovascular outcomes of sodium-glucose co-transporter-2 (SGLT2) inhibitors in a real world setting by analyzing electronic medical records.
J Clin Hypertens (Greenwich) . 2012; 14:588–592. © 2012 Wiley Periodicals, Inc. Blood pressure (BP) reductions when combining blockers of the renin‐angiotensin system (RAS) and β‐blockers have generally not been shown to be greater than for individual agents, possibly because overlapping mechanisms action. The authors tested additivity β‐blocker nebivolol, which has vasodilating activity, with angiotensin‐converting enzyme inhibitor lisinopril in patients stage 2 diastolic hypertension. BP...
Aims To evaluate initial blood pressure effects of the angiotensin II antagonist losartan (L) immediately after switching from an ACE inhibitor (captopril, C). Methods Two‐phase multicentre randomized study in 177 outpatients with mild to moderate essential hypertension. For 6 weeks all patients received 25 mg C twice daily. Then they were double‐blind switch for another 50 L once daily ( n =110) or maintain =55). On first day underwent ambulatory measurement (ABPM). Results Within 12 h...
Context In the face of further waves COVID-19 pandemic, it becomes essential to find a balance between protective actions guard public health and restrictive measures which can collapse our economy. Background As basis for decisions, officials still rely on metrics that were helpful in beginning pandemic but are now not precise enough focused targeted approach keep spread infection under control. This lead mistrust, “pandemic tiredness”, cause unnecessary damage economy without having...